Table of Contents
What changed
Revenue fell 39.7% to NZ$2.6m from NZ$4.3m, driven by the disclosed divestments of Eastgate and Stoddard Road. Profit before tax collapsed from a NZ$0.1m loss to a NZ$4.7m loss, and NPAT swung from a NZ$0.3m profit to the same NZ$4.7m loss. Operating cash flow turned negative (−NZ$0.2m vs +NZ$0.4m), and cash on hand declined modestly to NZ$4.7m. The balance sheet, however, moved the other way: gross borrowings fell 28.0% to NZ$35.0m after Stoddard Road sale proceeds of NZ$36.75m were applied to debt, cutting net debt from roughly NZ$42.9m to NZ$30.2m. Total assets contracted 13.3% to NZ$192.4m and equity fell 11.3% to NZ$141.8m. NTA per share declined to NZ$0.391 from NZ$0.441.
What matters
- PBT is the cleaner read, and it deteriorated sharply. The reported NPAT swing flatters the prior period, where a large tax benefit produced a −345% effective tax rate; HY24 carried no such benefit. On a PBT basis, losses widened by NZ$4.6m, reflecting both the revenue loss from divested assets and likely revaluation/financing drag rather than operating improvement.
- Balance-sheet direction is the offsetting positive. Net debt is down roughly NZ$12.7m versus HY23, and the asset-sale strategy explicitly targets a zero-debt, cash-reserve position post-Munroe Lane. That is a genuine structural improvement in leverage, even as the earning base shrinks.
- The earning asset base is now materially smaller. Annualised HY24 revenue of NZ$5.2m is still below the FY23 anchor of NZ$6.4m, and the remaining portfolio carries a development asset (Munroe Lane) that is not yet a stabilised income contributor.
Expectations
No forward-period guidance, quantified targets, or forward-work pipeline were disclosed in the excerpted materials. Second-half shape from FY23 is of limited use because FY23 full-year NPAT was dominated by a NZ$13.0m loss concentrated almost entirely in the second half (HY23 was only −2.3% of full-year NPAT), implying revaluation or one-off charges in 2H rather than a clean operating seasonality signal. Against that backdrop, the release supports a narrative of ongoing portfolio contraction and debt reduction; it does not support any claim about a return to profitability or a stabilised revenue base.
Quality of result
Low. Revenue is genuinely lower because the income-producing assets have been sold — that is durable in direction but not in the sense of a recovering earnings stream. Operating cash flow is now negative, and pre-lease free cash flow was −NZ$6.1m after NZ$5.8m of investment-property capex; the investing-section inflow was the Stoddard Road disposal, not recurring cash generation. The prior-period NPAT profit was substantially tax-benefit-driven, so the year-on-year NPAT gap overstates the underlying operating swing — but even on PBT the result is clearly weaker. Working-capital interpretation is unreliable given the receivables line is reported as a negative balance in HY24.
Unresolved
- What is the expected stabilised income contribution from Munroe Lane, and on what timeline does it offset the revenue lost from divestments?
- Is the company proceeding to a wind-up or recapitalisation? The prior-period commentary flagged shareholder engagement on next steps, but no current-period update was extracted.
- No current-period AFFO reconciliation was provided despite AFFO being the company's preferred operating measure historically — what does AFFO look like on the shrunken portfolio?
- What drove the NZ$4.6m PBT deterioration beyond the revenue decline — revaluation, financing costs, or transaction costs? The excerpts do not decompose it.
- The NZ$0.391 figure tagged as "interim dividend per share" in the extraction matches NTA per share; prior-period commentary notes the dividend was suspended in March 2022, so there appears to be no cash dividend component this period.
This briefing cannot assess valuation (no share price or market capitalisation supplied) or the expected earnings contribution from Munroe Lane once completed.
Key metrics
| Metric | HY24 | HY23 | Change |
|---|---|---|---|
| Revenue | $2.6m | $4.3m | -39.7% ↓ |
| Net profit after tax | −$4.7m | $0.3m | -1705.1% ↓ |
| Net cash inflow from operating activities | −$0.2m | $0.4m | -166.4% ↓ |
| Interim dividend per share | 39.1c | 44.1c | -11.3% ↓ |
| Operating profit | −$0.1m | −$0.1m | -101.5% ↓ |
| Profit before tax | −$4.7m | −$0.1m | -3832.5% ↓ |
| Cash and cash equivalents | $4.7m | $5.6m | -16.2% ↓ |
| Total assets | $192.4m | $221.8m | -13.3% ↓ |
Reference: annolyse.ai/briefings/apl-hy24
Analytical metrics
| Metric | HY24 | HY23 | Context |
|---|---|---|---|
| FCF pre-lease | −$6.1m | −$40.2m | +$34.1m |
| FCF / NPAT | 128.2% | n/m | complementary conversion metric |
| Capex % revenue | 222.8% | 938.7% | — |
| Capex | −$5.8m | −$40.6m | +$34.8m |
| Trade debtors | −$0.2m | $1.1m | −$1.4m |
| Debtor days | -15.8 | 47.5 | -63.3 days |
| Net debt | $30.2m | $42.9m | −$12.7m |
| Gross borrowings | $35.0m | $48.6m | −$13.6m |
| HY23 share of FY23 revenue | 67.8% | — | Other half was 32.2% |
| HY23 share of FY23 NPAT | -2.3% | — | Other half was 102.3% |
| Profit from continuing operations | — | $0.3m | — |
Reference: annolyse.ai/briefings/apl-hy24
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.